Transaction #27932 · Form 4 · 0001172659-26-000002
Fortress Biotech, Inc. · Stock award · common stock, par value $0.001
Fortress Biotech, Inc. · Transacted January 1, 2026 · Filed January 5, 2026
What does this filing report?
An SEC Form 4 filing for Fortress Biotech, Inc. records a stock award involving common stock, par value $0.001 on January 1, 2026. The reported quantity was 27,322. The filing date is January 5, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Fortress Biotech, Inc.
- Company CIK
- 0001429260
- Security type
- Non-derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 27,322
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 192,397
- Ownership description
- Not reported
- SEC acceptance time
- Jan 5, 2026, 4:30 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- LOBELL J JAY ↗
Director
CIK 0001172659
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Filing footnotes & remarks
- F1
- The Reporting Person was granted 27,322 shares of restricted stock pursuant to the Issuer's 2013 Stock Incentive Plan, as amended. One-third of the shares will vest on each of January 1, 2027, 2028, and 2029, subject to continued service. The Reporting Person elected to defer 100% of these restricted shares pursuant to the Issuer's Deferred Compensation Plan for Directors and instead received deferred share units that are subject to the same vesting conditions. Vested deferred shares will be delivered to the Reporting Person in January of the year following the Reporting Person's termination of service, or earlier upon their death or change in control of the Issuer.
- F2
- Total holdings include 76,705 shares underlying deferred restricted stock units.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.